Piedmont Healthcare

Blood pressure lowering with alcohol-mediated renal denervation using the Peregrine infusion Catheter is independent of injection site location (2021) Mahfoud F, Bertog S, Lauder L, Bohm M, Schmid A, Wojakowski W, Parise H, et al. Journal article Differences in patient and physician perspectives on pharmaceutical therapy and renal denervation for the management of hypertension (2021) Schmieder R, Kandzari DE, Wang TD, Lee YH, Lazarus G, Pathak A Journal article Confounding Factors in Renal Denervation Trials Revisiting Old and Identifying New Challenges in Trial Design of Device Therapies for Hypertension (2020) Kandzari DE, Mahfoud F, Bhatt DL, Boehm M, Weber MA, Townsend RR, Hettrick DA, et al. Journal article, Review article Impact of Renal Denervation on Plasma Renin Activity and Relationship of Baseline Plasma Renin Activity to Blood Pressure Lowering Response to Renal Denervation in the SPYRAL HTN-OFF MED Pivotal trial (2020) Mahfoud F, Townsend R, Kandzari D, Kario K, Schmieder R, Tsioufis K, Boehm M, et al. Conference contribution Proceedings from the 3rd European Clinical Consensus Conference for clinical trials in device-based hypertension therapies (2020) Mahfoud F, Azizi M, Ewen S, Pathak A, Ukena C, Blankestijn PJ, Böhm M, et al. Journal article Alcohol-mediated renal sympathetic neurolysis for the treatment of hypertension: The Peregrine™ infusion catheter (2020) Bertog S, Sharma A, Mahfoud F, Pathak A, Schmieder R, Sievert K, Papademetriou V, et al. Journal article, Review article Effect of renal denervation in attenuating the stress of morning surge in blood pressure: post-hoc analysis from the SPYRAL HTN-ON MED trial (2020) Kario K, Weber MA, Böhm M, Townsend RR, Mahfoud F, Schmieder R, Tsioufis K, et al. Journal article Correction to: Rationale and design of two randomized sham‑controlled of catheter‑based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN‑OFF MED Pivotal) and presence (SPYRAL HTN‑ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design (Clinical Research in Cardiology, (2020), 109, 3, (289-302), 10.1007/s00392-020-01595-z) (2020) Böhm M, Townsend RR, Kario K, Kandzari D, Mahfoud F, Weber MA, Schmieder R, et al. Journal article, Erratum Rationale and design of two randomized sham-controlled trials of catheter-based renal denervation in subjects with uncontrolled hypertension in the absence (SPYRAL HTN-OFF MED Pivotal) and presence (SPYRAL HTN-ON MED Expansion) of antihypertensive medications: a novel approach using Bayesian design (2020) Böhm M, Townsend RR, Kario K, Kandzari D, Mahfoud F, Weber MA, Schmieder R, et al. Journal article Implementation of Bayesian Study Design in the SPYRAL HTN-OFF MED Pivotal Trial (2019) Boehm M, Townsend R, Weber M, Kandzari D, Mahfoud F, Kario K, Schmieder R, et al. Conference contribution